#socc23 — Public Fediverse posts

Join us Thursday, June 8, at noon CT/1 pm ET for a special webinar, “New BIG data resources on St. Jude Cloud.” Panelists from St. Jude will discuss and perform a live demo of the Pediatric Cancer Knowledgebase (PeCanV2) and Survivorship Portal. Register today. https://bit.ly/SOCC23-MAS
#SOCC23 #ChildhoodCancer #BigData #DataScience

Join Thurs, May 25, at noon CT/1 pm ET as Dr. Kim Nichols of #StJude presents “Hereditary Predisposition to Cancer: At the Tip of the Iceberg.” She’ll discuss the prevalence & spectrum of #cancer predisposing #GermlineVariants in children and young adults, how these variants influence cancer #phenotypes & outcomes, and how #germline info impacts #ClinicalCare—including approaches to #CancerSurveillance & treatment. Register. https://bit.ly/SOCC23-MAS #SOCC23 #ChildhoodCancer #CancerPredisposition

Join Thurs, May 25, at noon CT/1 pm ET as Dr. Kim Nichols of #StJude presents “Hereditary Predisposition to Cancer: At the Tip of the Iceberg.” She’ll discuss the prevalence & spectrum of #cancer predisposing #GermlineVariants in children and young adults, how these variants influence cancer #phenotypes & outcomes, and how #germline info impacts #ClinicalCare—including approaches to #CancerSurveillance & treatment. Register. https://bit.ly/SOCC23-MAS #SOCC23 #ChildhoodCancer #CancerPredisposition

Join Thurs, May 25, at noon CT/1 pm ET as Dr. Kim Nichols of #StJude presents “Hereditary Predisposition to Cancer: At the Tip of the Iceberg.” She’ll discuss the prevalence & spectrum of #cancer predisposing #GermlineVariants in children and young adults, how these variants influence cancer #phenotypes & outcomes, and how #germline info impacts #ClinicalCare—including approaches to #CancerSurveillance & treatment. Register. https://bit.ly/SOCC23-MAS #SOCC23 #ChildhoodCancer #CancerPredisposition

Join us Thurs, May 18, at noon CT/1 pm ET as Dr. Jeffery Klco of #StJude presents “New mechanistic insights into the development of pediatric myeloid tumors.” The presentation will highlight the current mechanistic understanding of how newly identified mutations drive abnormal #myeloid development and how these new #GeneticAlterations can be used to develop new #classification systems and establish new #TherapeuticStrategies. Register today. https://bit.ly/SOCC23-MAS #SOCC23 #ChildhoodCancer

Join us Thurs, May 18, at noon CT/1 pm ET as Dr. Jeffery Klco of #StJude presents “New mechanistic insights into the development of pediatric myeloid tumors.” The presentation will highlight the current mechanistic understanding of how newly identified mutations drive abnormal #myeloid development and how these new #GeneticAlterations can be used to develop new #classification systems and establish new #TherapeuticStrategies. Register today. https://bit.ly/SOCC23-MAS #SOCC23 #ChildhoodCancer

Join us Thurs, May 18, at noon CT/1 pm ET as Dr. Jeffery Klco of #StJude presents “New mechanistic insights into the development of pediatric myeloid tumors.” The presentation will highlight the current mechanistic understanding of how newly identified mutations drive abnormal #myeloid development and how these new #GeneticAlterations can be used to develop new #classification systems and establish new #TherapeuticStrategies. Register today. https://bit.ly/SOCC23-MAS #SOCC23 #ChildhoodCancer

Join us Thursday, May 11, at noon CT/1 pm ET as Dr. Gerald Crabtree of #StanfordUniversity presents “Rewiring Cancer Drivers to Activate Apoptosis.” Register today. https://bit.ly/SOCC23-MAS #SOCC23 #Stanford #Apoptosis #CellDeath #ChildhoodCancer

Join us Thurs, May 4, at noon CT/1 pm ET as Dr. Sarah K. Tasian of Children’s Hospital of #Philadelphia presents “Emerging Therapies for Pediatric Leukemia.” Tasian will review the biology of childhood B-acute lymphoblastic #leukemia and discuss emerging precision medicine therapies and #immunotherapeutic approaches for specific leukemia subtypes. Register. https://bit.ly/SOCC23-MAS #SOCC23 #AcuteLymphoblasticLeukemia #PrecisionMedicine #Immunotherapy

Join us Thurs, May 4, at noon CT/1 pm ET as Dr. Sarah K. Tasian of Children’s Hospital of #Philadelphia presents “Emerging Therapies for Pediatric Leukemia.” Tasian will review the biology of childhood B-acute lymphoblastic #leukemia and discuss emerging precision medicine therapies and #immunotherapeutic approaches for specific leukemia subtypes. Register. https://bit.ly/SOCC23-MAS #SOCC23 #AcuteLymphoblasticLeukemia #PrecisionMedicine #Immunotherapy

Join us Thurs, May 4, at noon CT/1 pm ET as Dr. Sarah K. Tasian of Children’s Hospital of #Philadelphia presents “Emerging Therapies for Pediatric Leukemia.” Tasian will review the biology of childhood B-acute lymphoblastic #leukemia and discuss emerging precision medicine therapies and #immunotherapeutic approaches for specific leukemia subtypes. Register. https://bit.ly/SOCC23-MAS #SOCC23 #AcuteLymphoblasticLeukemia #PrecisionMedicine #Immunotherapy

Join us Thurs, April 27 at noon CT/1 pm ET as Dr. Fernando Camargo of Boston Children’s Hospital presents “Lineage Histories and Function in the Hematopoietic System.” Camargo’s work is aimed at dissecting the lineage trees of developing tissues and how understanding where cells come from might provide insights into the developmental origins of cancer. Register. https://bit.ly/SOCC23-MAS #SOCC23 #CancerResearch #ClonalHematopoiesis

Join us Thurs, April 27 at noon CT/1 pm ET as Dr. Fernando Camargo of Boston Children’s Hospital presents “Lineage Histories and Function in the Hematopoietic System.” Camargo’s work is aimed at dissecting the lineage trees of developing tissues and how understanding where cells come from might provide insights into the developmental origins of cancer. Register. https://bit.ly/SOCC23-MAS #SOCC23 #CancerResearch #ClonalHematopoiesis

Join us Thurs, April 27 at noon CT/1 pm ET as Dr. Fernando Camargo of Boston Children’s Hospital presents “Lineage Histories and Function in the Hematopoietic System.” Camargo’s work is aimed at dissecting the lineage trees of developing tissues and how understanding where cells come from might provide insights into the developmental origins of cancer. Register. https://bit.ly/SOCC23-MAS #SOCC23 #CancerResearch #ClonalHematopoiesis

“Evolution of Our Understanding of WNT and SHH Medulloblastoma” is the topic when Dr. Amar Gajjar of #StJude presents The Science of Childhood Cancer lecture Thurs, April 20, at noon CT/1 pm ET. Register. https://bit.ly/SOCC23-MAS
#SOCC23 #StJudeResearch #BrainTumor #Medulloblastoma

“Harnessing Implementation Science to Improve Outcomes for Children with Cancer who Develop Critical Illness” is the topic when Dr. Asya Agulnik of #StJude presents the #SOCC23 lecture Thurs, April 13, at noon CT/1 pm ET. Register. https://bit.ly/SOCC23-MAS #SOCC23 #ChildhoodCancer #ImpSci

“Harnessing Implementation Science to Improve Outcomes for Children with Cancer who Develop Critical Illness” is the topic when Dr. Asya Agulnik of #StJude presents the #SOCC23 lecture Thurs, April 13, at noon CT/1 pm ET. Register. https://bit.ly/SOCC23-MAS #SOCC23 #ChildhoodCancer #ImpSci

Join us Thursday, March 30, at noon CT/1 pm ET as Dr. Miguel N. Rivera of Mass General and Harvard Medical School presents “Mechanisms of chromatin regulation by EWS fusion proteins.” Register. https://bit.ly/SOCC23-MAS #SOCC23 #ChildhoodCancer #Epigenetics #FusionOncogenes #ChromatinRegulation

Join us Thurs, March 30, at noon CT/1 pm ET as Dr. Kathrin M. Bernt of The Children’s Hospital of Philadelphia presents “HOX-high Leukemias in Childhood.” Bernt will give an update on recent molecular and clinical insights into the #biology and targeted therapy of #leukemias with high #HOXexpression and will discuss recently published advances. Register. https://bit.ly/SOCC23-MAS #SOCC23 #HOXHigh #ChildhoodCancer #InfantALL #CancerResearch

Join us Thurs, March 30, at noon CT/1 pm ET as Dr. Kathrin M. Bernt of The Children’s Hospital of Philadelphia presents “HOX-high Leukemias in Childhood.” Bernt will give an update on recent molecular and clinical insights into the #biology and targeted therapy of #leukemias with high #HOXexpression and will discuss recently published advances. Register. https://bit.ly/SOCC23-MAS #SOCC23 #HOXHigh #ChildhoodCancer #InfantALL #CancerResearch

Join us Thurs, March 23, at noon CT/1 pm ET as Dr. Maksim Mamonkin of #Baylor College of Medicine presents “CAR T-cells for T-cell Malignancies: Proving and Improving” and Dr. Giedre Krenciute of #StJude presents “What will it take to make CARTs effective for pediatric brain tumors?” Register. https://bit.ly/SOCC23-MAS #SOCC23 #TCells #CARTCells #CancerResearch #BrainTumors

Join us Thurs, March 23, at noon CT/1 pm ET as Dr. Maksim Mamonkin of #Baylor College of Medicine presents “CAR T-cells for T-cell Malignancies: Proving and Improving” and Dr. Giedre Krenciute of #StJude presents “What will it take to make CARTs effective for pediatric brain tumors?” Register. https://bit.ly/SOCC23-MAS #SOCC23 #TCells #CARTCells #CancerResearch #BrainTumors

“Building a Mind for Cancer” is the topic when Dr. Trey Ideker of UC San Diego presents the #SOCC23 lecture Thurs, March 2, noon CT/1 pm ET. In contrast to substantial progress in mapping #cancergenomes, systematic efforts to map cancer pathways are just beginning. Ideker will describe ongoing efforts to close this gap, including new #machinelearning approaches & generation of high-throughput proteomic datasets that systematically inform tumor cell architecture. Register. https://bit.ly/SOCC23-MAS

“The Dutch Childhood Cancer Survivor Study LATER; Results and Implications” is the topic when Leontien CM Kremer, MD, PhD, of Princess Maxima Center for Pediatric Oncology presents The Science of Childhood Cancer lecture Thursday, February 23, at noon CT/1 p.m. ET. During this presentation, Kremer will focus on the results and implications of the Dutch Childhood Cancer Survivor Study LATER (DCCSS-LATER). Register now. https://bit.ly/SOCC23-MAS
#SOCC23 #CancerResearch

“Clonal Hematopoiesis and the Origins of Blood Cancers” is the topic when Benjamin Ebert, MD, PhD, of Dana-Farber Cancer Institute presents this season’s first The Science of Childhood Cancer lecture Thursday, February 16, at noon CT/1 p.m. ET.
Ebert will discuss clonal hematopoiesis of indeterminate potential (CHIP) a common, age-associated condition in individuals who do not have a hematologic malignancy or altered blood counts. Register now. https://bit.ly/SOCC23-MAS
#SOCC23 #CancerResearch